Company
Headquarters: Cardiff, United Kingdom
Employees: 10
CEO: Ms. Penelope Jane McCormick
£7.2 Million
GBP as of Jan. 1, 2024
US$9.2 Million
Company | Market Cap (USD) |
---|---|
Abbott | $178.02 B |
Stryker Corporation | $126.48 B |
Boston Scientific Corporation | $112.32 B |
Medtronic | $98.95 B |
Edwards Lifesciences Corporation | $55.63 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
MyHealthChecked Plc, a home-testing healthcare company, develops and commercializes at-home healthcare and wellness test kits in the United Kingdom. The company provides MyLotus/MYLO products for trusted ovulation, conception, and fertility advice and tracking, as well as up to date information regarding fertility for customers. It also offers a range of at-home DNA and RNA tests; and COVID-19 PCR nasal swab test kit for at-home use. The company was formerly known as Concepta PLC and changed its name to MyHealthChecked Plc in December 2020. MyHealthChecked Plc was incorporated in 2008 and is headquartered in Cardiff, the United Kingdom.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
MyHealthChecked plc has the following listings and related stock indices.
Stock: LSE: MHC wb_incandescent